[kiryandil]

Heidi Przybyla (D-NBXi) is a KNOWN anti-hydroxychloroquine agitator and Resistance NB-Xi "news" bimbette.

She was shamelessly pumping the news about the fish-tank cleaner couple [end of March] as if it were a fact that Trump made them take it.

And now for the rest of the story:

I went to her Twitter feed, and she's pumping Gilead's Remdesivir like it's the Second Coming of Christ.

She's a pimp for Big Pharma.

[Zhang Fei]

[I went to her Twitter feed, and she’s pumping Gilead’s Remdesivir like it’s the Second Coming of Christ.]

---

Futures up a few % because of news that a Gilead clinical trial panned out. At this stage, if the drug works well, I’d have no problem giving $20b tax-free to Gilead to hand over the rights to this drug to all companies that want to make a generic version. It’s a pittance compared to the $trillions of damage sustained through month-long shutdowns.

The key difference between the Gilead drug and the quinine derivatives is that the Gilead drug cured 2/3 of the patients at an advanced stage of the disease. Someone I know who got the malaria drug and z-pak while on the ventilator died anyway.

---

https://www.bizjournals.com/sacramento/news/2020/04/16/uc-davis-clinical-trial-shows-promising-early.html?ana=yahoo&yptr=yahoo
[Nearly two-thirds of severely ill patients hospitalized with COVID-19 are responding well to a new drug, according to the early findings of a clinical trial that UC Davis Health participated in.

The university recently co-published its preliminary findings on the use of remdesivir, an antiviral drug, with early results indicating that the drug may be beneficial to patients with severe COVID-19 symptoms. The findings were published April 10 in The New England Journal of Medicine.]

[Revel]

They always have an agenda if they work for the MSM.

[RinaseaofDs]

Many thanks! That makes total sense.